Resource Logo
Voice of America

Less-Used HIV Treatment for African Children More Effective




 

The nearly 3 million children in sub-Saharan Africa who are living with HIV -- the virus that causes AIDS -- can be treated with one of two drugs to suppress the virus.

Nevirapine is the drug of choice in most of those countries, because it costs less than the other - efavirenz - and is more widely available in a formula for children. However, a new study by researchers in Philadelphia and Botswana comparing the effectiveness of the two drugs found that initial treatment with efavirenz produced better outcomes for children than nevirapine.

Lead author Elizabeth Lowenthal, of The Children's Hospital of Philadelphia, says this study could change the standard of care in those parts of the world where most HIV-infected children live.

Previous studies favoring efavirenz over nevirapine in adults have led many countries, including ones in resource-limited settings, to change their recommendations for adult treatment.

Lowenthal points out that negotiations between health officials and pharmaceutical companies have resulted in lower prices for bulk drug purchases. University of Pennsylvania professor Robert Gross, the study's senior author, says "more work should be done to make efavirenz a more financially viable option for children on anti-retroviral therapy in these resource-limited settings."

Their study of the two antiretroviral treatments is published in The Journal of the American Medical Association.



 


Copyright © 2013 -Voice of America, Publisher. All rights reserved to Voice of America.You are welcome to use any material that is published by voanews.com, or you may link to any of the web pages that Voice of America has published on the internet. There is no need to request further permission. Should you wish to establish a link to any VOA web pages, please send your request to pubaff@ibb.gov. We would appreciate that credit for any use of VOA material be given to voanews.com, Voice of America, or VOA, and we ask that you not abridge or edit any VOA material which you may use.



Information in this article was accurate in April 30, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.